|
Agenda |
Based on feedback from previous attendees, this year's conference will feature a new format that will allow for more personal interaction. In addition to the traditional lecture style presentations, take advantage of more intimate roundtable sessions where you will be able to communicate and network directly with your peers on key subject areas.
|
 |
| Conference Highlights |
Our faculty will include industry and provider experts, as well as key Federal and State officials who help administer the 340B, Medicaid drug rebate, and Medicare Part D programs. The Office of Pharmacy Affairs and other government agencies will provide presentations and will be available to answer your questions. Topics to be discussed include:
- How the 340B program will be impacted by a new president
- Special half-day workshop on the basics of the 340B program
- Special half-day workshop on Patient Assistance Programs
- Federal government update from OPA, the 340B Prime Vendor Program and the Pharmacy Services Support Center
- Legislative Update from 340B experts
- Stakeholder breakout sessions and topic area roundtable discussions
- Track One:
- Inventory management
- Split billing
- Anti-diversion
- Medicaid billing requirements
- How to establish and effectively monitor a 340B contract pharmacy arrangement
- Track Two:
- Government's proposed changes to the 340B definition of patient
- Legislation to expand 340B to new entities and extend the program to inpatient drugs
- Enrollment of children's hospitals into the program
- Government's proposed expansion of the number of 340B contract pharmacies
- Increased transparency of 340B calculations
- Update on 340B Prime Vendor Program, including contracts with manufacturers for subceiling discounts and efforts to improve pricing accuracy
- Efforts to prevent drug diversion and price overcharges, including an update on federal investigations and enforcement
- Latest on NDC data collection and physician-administered drug rebates and its impact on stakeholders
- Impact of NDC reporting and rebate collection on providers, industry and advocacy groups
- Other DRA measures impacting the 340B program including changes to average manufacturer price (AMP), best price and nominal prices
|
|
| |
Conference Attire: Business Casual
Continuing Education Credits for Pharmacists will be Available! |
|
|
|
